<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03083951</url>
  </required_header>
  <id_info>
    <org_study_id>13117</org_study_id>
    <nct_id>NCT03083951</nct_id>
  </id_info>
  <brief_title>Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)</brief_title>
  <acronym>CMELL</acronym>
  <official_title>Complete Mesocolon Excision vs Locoregional Lymphadenectomy in Sigmoid Colon Cancer (CMELL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pere Planellas Giné</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, controlled clinical trial comparing lymphadenectomy with extended inferior
      mesenteric artery ligation (complete mesocolon excision: which includes lymphoma tissue from
      the origin of the inferior mesenteric vein) with conventional locoregional lymphadenectomy in
      patients undergoing laparoscopic sigmoidectomy for sigmoid cancer.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial, single blind (the patient does not know the group to which it has been assigned) of patients undergoing laparoscopic sigmoid colon cancer resection. In all patients a lymphadenectomy with a high ligation of the Lower Mesenteric Artery will be performed. In patients in group 1A, lymphadenectomy will also include the lymphogranular tissue that accompanies the inferior mesenteric vein from its origin (complete mesocolon excision). In patients in group 1B, a conventional lymphadenectomy will be performed only from the origin of the inferior mesenteric artery without including the lymphatic tissue of the origin of the inferior mesenteric vein.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>The patient does not know the group to which it has been assigned.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Total number of lymph nodes and lymph node ratio.</measure>
    <time_frame>30 days</time_frame>
    <description>To compare the total number of lymph nodes resected and the lymph node ratio (definded as ratio of lymph nodes with tumor metastasis to the total lymph nodes resected) between the two arms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Local recurrence</measure>
    <time_frame>5 years</time_frame>
    <description>To compare the tumor local recurrence rate between the two arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>5 years</time_frame>
    <description>To compare the survival rate (deaths from cancer) between the two arms</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>90 days</time_frame>
    <description>Postoperative complications within 90 days after surgery (Clavien-Dindo classification).</description>
  </other_outcome>
  <other_outcome>
    <measure>Anastomotic leakage</measure>
    <time_frame>90 days</time_frame>
    <description>To compare the incidence of anastomotic leakage according to the classification of the International Group for Rectal Cancer Study.</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative outcomes: duration of surgery</measure>
    <time_frame>1 day</time_frame>
    <description>To compare the duration of surgery measured in minutes between the two arms</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative outcomes: surgical bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>To compare the surgical bleeding measured in ml between the two arms</description>
  </other_outcome>
  <other_outcome>
    <measure>Intraoperative outcomes: surgical conversion</measure>
    <time_frame>1 day</time_frame>
    <description>To compare the incidence of surgical conversion to laparotomy between the two arms</description>
  </other_outcome>
  <other_outcome>
    <measure>Genitourinary dysfunction assesed by ICIQ-SF questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>To compare the Genitourinary dysfunction between the two arm measured by ICIQ-SF questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Defecatory dysfunction assesed by FSFI and erectile dysfunction questionnaires</measure>
    <time_frame>1 year</time_frame>
    <description>To compare the defecatory dysfunction between the two arms measured by FSFI and erectile dysfunction questionnaires</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Sigmoid Cancer</condition>
  <arm_group>
    <arm_group_label>Complete Mesocolon Excision</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A high tie of the inferior mesenteric artery (IMA) should be attempted. The inferior mesenteric vein section at the Treitz angle should be performed. The lymphatic tissue that accompanies the inferior mesenteric vein should be added.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional Locoregional Lymphadenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A high tie of the inferior mesenteric artery (IMA) should be attempted. Lymphadenectomy of the lymphatic tissue that accompanies the IMA will be performed. The inferior mesenteric vein section could be performed at the discretion of the surgeon.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Complete mesocolon excision</intervention_name>
    <description>Laparoscopic sigmoidectomy with lymphadenectomy of the lymphatic tissue that accompanies the inferior mesenteric vein and a high tie ligation of the inferior mesenteric artery (complete mesocolon excision)</description>
    <arm_group_label>Complete Mesocolon Excision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional locoregional lymphadenectomy</intervention_name>
    <description>Laparoscopic sigmoidectomy with lymphadenectomy of the lymphatic tissue that accompanies the inferior mesenteric artery and a high tie ligation of the inferior mesenteric artery with or without section of inferior mesenteric vein.</description>
    <arm_group_label>Conventional Locoregional Lymphadenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing programmed surgery for laparoscopic sigmoid colon cancer.

          -  Age ≥ 18 years and &lt;80 years.

          -  Histology of adenocarcinoma or adenoma without chemotherapy or neoadjuvant
             radiotherapy.

          -  Any T, any N, M0.

          -  Intention of resection R0.

          -  Informed consent signed by the patient and the investigator.

        Exclusion Criteria:

          -  Colorectal tumor with histology other than adenocarcinoma or adenoma.

          -  Colon cancer located in the right colon, transverse, splenic or non-sigmoid left
             colon.

          -  Metastatic disease (M1).

          -  History of colorectal cancer surgery, different from a local excision.

          -  Inflammatory bowel disease with anatomopathological confirmation.

          -  Patients with psychiatric illness, addiction or any disorder that pmpedes the
             understanding of informed consent.

          -  Inability to read or understand any of the languages of the informed consent (Catalan,
             Spanish).

          -  Another synchronous malignant disease.

          -  Emergency surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pere Planellas Giné</last_name>
    <phone>972 940 256</phone>
    <phone_ext>2256</phone_ext>
    <email>pereplanellas@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antoni Codina Cazador</last_name>
    <phone>972 940 256</phone>
    <phone_ext>2256</phone_ext>
    <email>acodinac.girona.ics@gencat.cat</email>
  </overall_contact_backup>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2017</study_first_submitted>
  <study_first_submitted_qc>March 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2017</study_first_posted>
  <last_update_submitted>August 24, 2017</last_update_submitted>
  <last_update_submitted_qc>August 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</investigator_affiliation>
    <investigator_full_name>Pere Planellas Giné</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Complete mesocolon excision</keyword>
  <keyword>Sigmoid cancer</keyword>
  <keyword>Colorectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Sigmoid Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

